Acrew Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Glympse Bioglympsebio.comMay 2020AcquiredSEC filingmedium confidence
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)Sirshendu Roopom Banerjee(Executive Officer)
BoardTheresia Guow(Director)Amy Schulman(Director)inStan Lapidus(Director)
Board seatTheresia Gouw· per SEC Form D · $46.7M raise · filed Jul 2021
Co-investorsGreatPoint VenturesAspect VenturesCatalio Capital ManagementDns CapitalNew Leaf Venture PartnersPolaris Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.